NeuroBo Pharmaceuticals (NRBO)
NASDAQ:NRBO
US Market
Holding NRBO?
Track your performance easily

NeuroBo Pharmaceuticals (NRBO) Stock Investors

322 Followers
Based on 757,311 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NRBO
On average, investors allocate 0.00% of their portfolios to NRBO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,311 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NRBO

1.7%
Last 7
Days
4.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NRBO, out of 757,311 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NRBO Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,468 investors who made their portfolios public
The table shows changes in NRBO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NRBO Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.58%
-1.48%
+0.87%
34.22B
Consumer Cyclical
Coherus Biosciences
2.45%
-0.19%
-1.47%
119.82M
Healthcare
Plug Power
5.11%
-1.24%
-2.96%
1.84B
Industrials
Blink Charging Co
5.32%
-1.79%
-3.85%
190.16M
Industrials
Marathon Digital Holdings
5.33%
-0.71%
-1.46%
4.67B
Financial
Enphase Energy
5.04%
-1.63%
-4.99%
16.05B
Technology
XPeng, Inc. ADR
5.47%
-1.34%
-2.89%
8.61B
Consumer Cyclical
Bristol-Myers Squibb
3.44%
-1.33%
-2.60%
100.34B
Healthcare
RTX
4.25%
-1.35%
-0.74%
157.94B
Industrials
Block
4.21%
-1.17%
-2.73%
41.45B
Technology
Based on the activity of 757,311 active portfolios
Open your Smart Portfolio

NRBO Investor Analysis

NRBO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.9%
of NRBO holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
NRBO investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
57.1%
of NRBO holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
NRBO investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
31.0%
of NRBO holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of NRBO stock investors
See who invests in NRBO according to age group and performance.

FAQ

How many retail Investors hold NRBO?
<0.1% of TipRanks' retail investors hold NRBO in their portfolios.
    What is NRBO Investor Sentiment?
    NRBO’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of NRBO in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of NRBO in the last 7 days.
        What percentage of retail investors changed their holding of NRBO in the last 30 days?
        ▼ 4.8% of TipRanks' retail investors changed their holding of NRBO in the last 30 days.
          What is the average age of retail investors who hold NRBO?
          The average age of NRBO Holders is between 35–55.
            What other stocks have NRBO investors also bought?
            NRBO Investors also bought DKNG, CHRS, PLUG, BLNK, MARA, ENPH, XPEV, BMY, RTX, SQ.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              EXELExelixis
              AVDLAvadel Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis